Track ACRO Biomedical , Ltd.'s total liabilities ($45M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), 6748.TWO shows a total liabilities of $45M. That compares with $26M in the prior-year period — up 72.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 6748.TWO's total liabilities is now $45M (was $26M) — a 72.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether ACRO Biomedical , Ltd. is outperforming or lagging.
Tracking 6748.TWO's total liabilities over time shows whether ACRO Biomedical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $45M That compares with $26M in the prior-year period — up 72.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total liabilities page, Stockcircle has ACRO Biomedical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $45M) with ownership activity and broader fundamentals.